期刊文献+

Tet-off系统对小鼠骨髓基质细胞中人IFN-γ基因表达的调控作用 被引量:1

Regulating Human Interferon-gamma Gene Expression in Marrow Stromal Cells in Mice by Tet-off System
下载PDF
导出
摘要 背景与目的:本实验室已成功构建了质粒pTre-IFN-γ,并证实四环素基因调控系统(Tet-off system)能在体外调控人γ-干扰素(interferon-gamma,IFN-γ)基因在小鼠骨髓基质细胞(marrow stromal cells,MSCs)中的表达。本实验进一步研究Tet-off系统体外调控的可逆性,以及其对小鼠MSCs中人IFN-γ基因表达的调控作用。方法:脂质体介导pTet-off和pTre-IFN-γ质粒共转染小鼠MSCs。用ELISA法检测MSCs培养液中人IFN-γ蛋白的分泌量。把共转染后的MSCs回输给BALB/c裸小鼠,用实时荧光定量RT-PCR方法检测各组BALB/c裸小鼠脾组织中的IFN-γmRNA含量。结果:用ELISA法可检测到共转染后的MSCs培养液中有IFN-γ蛋白分泌,分泌高峰在前72h内;共转染后84h加入含300ng/mL盐酸四环素的培养液培养12h,每1×107个细胞的分泌量为(67.11±22.14)pg,无四环素处理组为(319.96±29.04)pg,两组相比差异有统计学意义(P<0.001);去除四环素后,IFN-γ蛋白分泌显著增加(P=0.032)。用实时荧光定量RT-PCR可检测到回输共转染MSCs的各组BALB/c裸小鼠脾组织中均有IFN-γmRNA转录,不用四环素处理组最高,达(1.5±0.7)×105copy·(100mg)-1,定期四环素处理组为(6.9±5.3)×102copy·(100mg)-1(P<0.001),接受1次四环素处理组表达量介于前两者之间,差异均有统计学意义(P<0.01)。结论:Tet-off系统在体外和体内都可以迅速、有效地调控人IFN-γ基因在小鼠MSCs中的表达,而且调控是可逆的。 BACKGROUND & OBJECTIVE. We have constructed plasmid “pTre-IFN-γ” and proved that the Tet-off system could regulate the expression of human interferon-gamma (IFN-γ) gene in murine marrow stromal cells in vitro. This study was to investigate the regulatory reversibility of Tet-off system and its effect on the expression of human IFN-γ gene in murine marrow stromal cells in mice. METHODS: Plasmids pTet-off and pTre-IFN-γ were cotransfected into mudne marrow stromal cells. The expression of IFN-γ in marrow stromal cells was detected with ELISA. The marrow stromal cells were transfused into BABL/c naked mice after co-transfection. The expression of IFN-γ mRNA in the spleen was detected by real-time fluorescent quantitative reverse transcription-polymerase chain reaction (RT-PCR). RESULTS: IFN-γ protein was detected in the culture solution of marrow stromal cells after cotransfection. The secretion peak appeared within the first 72 h. The protein level of IFN-γ was significantly lower in 300 ng/ml tetracycline hydrochloridetreated marrow stroma cells than in untreated cells [(67.11±22.14) pg/1×10^7 cells vs. (319.96±29.04) pg/1×10^7 cells, P〈0.001]; its expression was increased when removed tetracycline hydrochloride (P=0.032). The expression of human IFN-γ mRNA was detected in the spleen. The mRNA level of IFN-γ was significantly higher in untreated group than in continuous tetracycline hvd rochloride-treated group L- ( 1.5±0.7 ) ×10^-1 copies. ( 100 mg )^-1 vs. (6 9±5.3) ×10^2 copies·(100 mg)^-1, P〈0.001]; its expression in the mice received tetracycline hydrochloride for one single time lay between the above two groups with significant difference. CONCLUSION: In mice, Tet-off system could rapidly, efficiently and reversibly regulate the expression of human IFN-γ gene in marrow stromal cells in vitro and in vivo.
出处 《癌症》 SCIE CAS CSCD 北大核心 2008年第1期46-51,共6页 Chinese Journal of Cancer
基金 国家自然科学基金资助项目(No.30471976) 广东省科技计划项目(No.2004-139)~~
关键词 骨髓基质细胞 Tet-off系统 IFN-Γ基因 调控 小鼠 Marrow stromal cells Tet-off system IFN-γ RegulationMouse
  • 相关文献

参考文献17

  • 1Anderson W F, Blaese R M, Culver K, et al. The ADA human gene therapy clinical protocol: points to consider response with clinical protocol [J]. Hum Gene Ther, 1990,1(3) :331-362.
  • 2Haynesworth S E, Goshima J, Goldberg V M, et al. Characterization of cells with osteogenic potential from human marrow [J].Bone, 1992,13(1) :81-88.
  • 3Banf A, Muraglia A, Dozin B, et al. Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: implications for their use in cell therapy[J]. Exp Hematol, 2000,28(6) :707-715.
  • 4Ding L, Lu S, Batchu R, et al. Bone marrow stromal cells as a vehicle for gene transfer [J]. Gene Ther, 1999,6 (9) : 1611 - 1616.
  • 5Krebsbach P H, Zhang K, Malik A K, et al. Bone marrow stromal cells as a genetic platform for systemic delivery of therapeutic proteins in vivo: human factor Ⅸ model [J]. J Gene Med, 2003,5(1): 11-17.
  • 6Min Y H, Li G X, Jang J H, et al. Long-term bone marrow culture-derived stromal fibroblasts as a potential target for gene therapy in acute myelogenous leukemia[J].Leuk Res, 2002,26 (4) :369-376.
  • 7Li X, Lu Y, Huang W, et al. In vitro effect of adenovirus- mediated human gamma interferon gene transfer into human mesenchymal stem cells for chronic myelogenous leukemia [J]. Hematol Oncol, 2006,24(3) : 151-158.
  • 8袁建辉,贺智敏,余艳辉,陈主初.Tet调控的乳腺癌耐受蛋白表达细胞系的建立及功能研究[J].癌症,2004,23(10):1127-1133. 被引量:7
  • 9Hu S X, Ji W, Zhou Y, et al. Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression [J].Cancer Res, 1997,57(16):3339- 3343.
  • 10Wilkinson J, Di X, Schonig K, et al. Tissue-specific expression of ferritin H regulates cellular iron homoeostasis in vivo [J]. Biochem J, 2006,395(3) :501-507.

二级参考文献31

  • 1袁建辉,贺智敏,余艳辉,陈主初.Tet调控的乳腺癌耐受蛋白表达细胞系的建立及功能研究[J].癌症,2004,23(10):1127-1133. 被引量:7
  • 2徐海鹏,吕跃,李晓青,谭银多,耿其荣,陈晓勤.Ad/IFNγ转染的骨髓基质细胞的体内抗白血病作用[J].广东医学,2006,27(6):790-792. 被引量:1
  • 3Doyle LA, Yang W, Abruzzo LV, et al. A multidrug resistance transporter from human MCF-7 breast cancer cells [J]. Proc Natl Acad Sci USA, 1998, 95(26): 15665-15670.
  • 4Miyake K, Mickey LA, Litman T, et al. Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes [J] .Cancer Res, 1999, 59(1): 8-13.
  • 5Minderman H, Suvannasankha A, O'Loughlin KL, et al. Flow cytometric analysis of breast cancer resistance protein expression and function [J]. Cytometry, 2002, 48 (2): 59-65.
  • 6Kage K, Tsukahara S, Sugiyama T, et al. Dominant-negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S-S dependent homodimerization [J]. Int J Cancer, 2002, 97 (5): 626-630.
  • 7Allikmets R, Schriml LM, Hutchinson A, et al. A human placentaspecific ATP-binding cassette gene(ABCP) on chromosome 4q22that is involved in multidrug resistance [J]. Cancer Research,1998, 58(23): 5337-5339.
  • 8Kanzaki A, Toi M, Nakayama K, et al. Expression of multidrug resistance-related transporters in human breast carcinoma [J]. Jpn J Cancer Res, 2001,92(4): 452-458.
  • 9Ross DD, Karp JE, Chen TT, et al. Expression of breast cancer resistance protein in blast cells from patients with acute leukemia [J]. Blood, 2000, 96(1): 365-368.
  • 10Kanzaki A, Toi M, Nakayama K, et al. Expression of multidrug resistance-related transporters in human breast carcinoma [J]. Jpn J Cancer Res, 2001,92(4): 452-458.

共引文献6

同被引文献8

  • 1Yan SUN,Xigu CHEN,Dong XIAO.Tetracycline-inducible Expression Systems:New Strategies and Practices in the Transgenic Mouse Modeling[J].Acta Biochimica et Biophysica Sinica,2007,39(4):235-246. 被引量:12
  • 2Jiang XC,Paultre F, Pearson TA, et al. Plasma sphingomyelin level as a risk factor for coronary artery disease [J ]. Arterioscler Thromb Vasc Biol,2000 ,20(12 ) : 2 614- 2 618.
  • 3Futerman AH, Stieger B, Hubbard AL, et al. Sphingomyelin synthesis in rat liver occurs predominantly at the eis and medial cisternae of the Golgi apparatus[J]. J Biol Chem, 1990, 265 (15) :8 650- 8 657.
  • 4Huitema K, van den Dikkenberg J, Brouwers JF, et al. Identification of a family of animal sphingomyelin synthases [J]. EMBO J ,2004,23(1 ) :33 - 44.
  • 5Meng A,Luberto C, Meier AP, et al. Sphingomyelin synthase as a potential target for D609-indueed apoptosis in U937 human monocytie leukemia cells[J]. Exp Cell Res, 2004,292 (2) :385 - 392.
  • 6Chen Z, Fitzgerald RL, Schonfeld G. Hypobetalipoproteinemic mice with a targeted apolipoprotein (Apo) B-27. 6-specifying mutation[J]. J Biol Chem ,2002,277(6) :14 135 -1 4145.
  • 7Lewis GF,Rader DJ. New insights into the regulation of HDL metabolism and reverse cholesterol transport [J]. Cir Res, 2005,96(12):1 221-1 232.
  • 8Dong JB, Wu MP, Jiang XC, et al. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice[J]. J Lipid Res, 2006,47: 1 307-1 314.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部